Jazz Pharmaceuticals Plc
(NASDAQ : JAZZ)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
ICLRICON plc -0.95%249.552.8%$140.56m
VRXValeant Pharmaceuticals International, Inc. -5.07%23.7914.1%$139.98m
HZNPHorizon Therapeutics Plc -1.22%85.375.4%$112.46m
BHCBausch Health Cos., Inc. -5.11%23.780.0%$102.35m
CTLTCatalent, Inc. -5.19%96.782.0%$102.12m
JAZZJazz Pharmaceuticals Plc -3.79%131.582.1%$84.27m
SAVACassava Sciences, Inc. -3.69%34.990.0%$82.39m
UTHRUnited Therapeutics Corp. -1.36%197.3513.9%$77.80m
ZGNXZogenix, Inc. -0.15%25.947.5%$77.79m
PRGOPerrigo Co. Plc -4.31%37.176.9%$47.10m
ARGXargenx SE -5.30%264.440.0%$45.85m
PCRXPacira Biosciences, Inc. -2.68%61.739.8%$27.91m
BRBRBellRing Brands, Inc. 2.99%25.150.0%$26.96m
IRWDIronwood Pharmaceuticals, Inc. -0.32%10.969.5%$22.75m
SAGESAGE Therapeutics, Inc. -3.53%36.867.6%$17.28m

Company Profile

Jazz Pharmaceuticals Plc operates as a biopharmaceutical company, which focuses on the identification, development and commercialization of pharmaceutical products in the areas of narcolepsy, oncology, pain and psychiatry. Its product portfolio includes: Xyrem, Xywav, Sunosi, Erwinaze, Vyxeos, Defitelio, and Zepzelca. The company was founded by Bruce C. Cozadd in March 2003 and is headquartered in Dublin, Ireland.